Skip to content

Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation

Transcutaneous Versus Arterial Carbon Dioxide Monitoring During Jet Ventilation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07211763
Enrollment
100
Registered
2025-10-08
Start date
2025-04-01
Completion date
2026-07-31
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Frequency Jet Ventilation, Liver Ablation

Keywords

jet ventilation

Brief summary

The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.

Detailed description

During percutaneous radio frequency ablation of liver tumours, jet. ventilation is used to minimise diaphragm movement. By not having conventional ventilation the interventional radiologist have better conditions to perform the treatment and minimising risk damaging adjacent tissue. Jet ventilation does however remove the possibility to monitor end tidal CO2, necessitating alternative monitoring to ensure adequate ventilation. At our institution we use transcutaneous and arterial blood gas monitoring. We aim to collect data on both modalities and compare the values using a repeat measure Bland-Altmann analysis. Study participants will be managed as per normal protocol and the only difference to the non-participators will be their contribution of prospective data for later analysis.

Interventions

OTHERNo Interventions

No intervention, solely data collection

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients undergoing percutaneous RF liver tumour ablation requiring jet ventilation

Exclusion criteria

* disease or condition. not compatible with jet ventilation

Design outcomes

Primary

MeasureTime frame
Difference in CO2 between TcCO2 and PaCO2during perioperative management

Countries

Sweden

Contacts

Primary ContactFredrik Olsen, MD PhD
fredrik.olsen@vgregion.se+46 313428169
Backup ContactCarl Hallgren, MD
carl.hallgren@vgregion.se+460313430286

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026